Cipla Ltd. | CIPLA | NSE - Pharmaceuticals


Performance  |  Valuation  |  Growth  |  Insiders  |  Summary
Balance Sheet  |  Income Statement  |  Cash Flow  |  Quarterly

Financial Summary Report of Cipla Ltd.



CIPLA
Cipla Ltd.

Rs. 1455.20
10-Dec-2024

5 Yr Performance

1 Yr Performance

Valuation



Analysis


Upgrade to Professional Membership

Peer Comparison


AstraZenca Pharma India Ltd.

Aurobindo Pharma Ltd.

Biocon Ltd.

Cadila Healthcare Ltd.

RPG Life Sciences Limited

Divis Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

FDC Ltd.

Fresenius Kabi Oncology Ltd.

Glaxosmithkline Pharmaceuticals Ltd.